Program
Oxaliplatin
Also written as “oxaliplatin”, “Oxaliplatin (SR96669)” and “oxaliplatin (OXA), levofolinate calcium (l-LV), 5-FU, panitumumab”.
Its studies are mostly in Colorectal Neoplasms · Stomach Neoplasms · Pancreatic Neoplasms · Rectal Neoplasms · Carcinoma, Hepatocellular, led by 9 companies.
Drug pageOxaliplatin: every studyMany companies study it; this page follows only the 66 they lead. All 854 studies, academic ones too, with its approvals and label.Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Sanofi | 360 open or running | phase 4since Aug 10, 2005 | Jan 6, 2001 | none ahead |
| Hoffmann-La Rocheits history only | 201 open or running | phase 4since Dec 18, 2007 | Sep 15, 2003 | Mar 22, 2027phase 1 · NCT06624085 |
| Prologue Research Internationalits history only | 30 open or running | phase 3since Jun 5, 2003 | May 6, 2001 | none ahead |
| Pfizerits history only | 21 open or running | phase 3since Oct 5, 2020 | Nov 6, 2007 | none ahead |
| Criteriumits history only | 10 open or running | phase 2since Sep 24, 2019 | Sep 24, 2019 | none ahead |
| GlaxoSmithKlineits history only | 10 open or running | phase 1since Sep 27, 2007 | Sep 27, 2007 | none ahead |
| Nang Kuang Pharmaceuticalits history only | 10 open or running | phase 2since Mar 28, 2011 | Mar 28, 2011 | none ahead |
| NovoCureits history only | 10 open or running | no phasesince Feb 20, 2020 | Feb 20, 2020 | none ahead |
| Sirtex Medicalits history only | 10 open or running | phase 3since Aug 13, 2008 | Aug 13, 2008 | none ahead |
Also a collaborator on its studies: Exelixis, Novartis, Clovis Oncology, Johnson & Johnson, Ono Pharmaceutical, Merck KGaA, Darmstadt, Germany, Eli Lilly, Parexel, Halozyme Therapeutics, BioLineRx, AbbVie, Zai Lab, Amgen, Bristol-Myers Squibb, Regeneron Pharmaceuticals and Yakult Honsha.
How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.
History and studies of Sanofi only; the figures above count every company.
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
Before these, 19 studies since Jan 6, 2001.
- Dec 12, 2006Phase 3 study in Stomach NeoplasmsNCT00411229 · 1,035 enrolled · China, Korea, Republic of, Taiwan
- Jan 11, 2007Phase 2 study in Rectal NeoplasmsNCT00421824 · 108 enrolled · Spain
- Feb 16, 2007Phase 2 study in Nasopharyngeal NeoplasmsNCT00436800 · 41 enrolled · Hong Kong
- May 9, 2007Phase 3 study in Carcinoma, HepatocellularNCT00471965 · 371 enrolled · China, Korea, Republic of, Taiwan and more
- Jul 10, 2007Phase 1 study in AdenocarcinomaNCT00499850 · 18 enrolled · Australia
- Nov 15, 2007Phase 2 study in Carcinoma, HepatocellularNCT00559455 · 38 enrolled · Korea, Republic of
- Jan 28, 20084 phase 2 studiesNCT00612495, NCT00611962, NCT00611754 and 1 more
- Oct 28, 2008Phase 2 study in Uterine NeoplasmsNCT00782041 · 11 enrolled · Thailand
- Dec 31, 2008Phase 2 study in Stomach NeoplasmsNCT00816543 · 41 enrolled · Korea, Republic of
- Sep 28, 2009Phase 2 study in Colorectal NeoplasmsNCT00988897 · Canada
- Apr 29, 2010Phase 3 study in Pancreatic NeoplasmsNCT01121848 · 108 enrolled · Canada
- Nov 19, 2010Phase 3 study in Carcinoma, HepatocellularNCT01245582
- Jan 10, 2012Phase 3 study in Stomach NeoplasmsNCT01515748 · 530 enrolled · Korea, Republic of
- Sep 13, 2013Phase 2 study in Colorectal Cancer MetastaticNCT01955629 · 4 enrolled · Italy
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 36 Sanofi leads, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT01955629Colorectal Cancer Metastatic · Italy | 2 | Terminated | Mar 2015 | 4 |
| NCT01515748Stomach Neoplasms · Korea, Republic of | 3 | Completed | Jan 21, 2019 | 530 |
| NCT01245582Carcinoma, Hepatocellular | 3 | Withdrawn | Feb 2014 | 0 |
| NCT01121848Pancreatic Neoplasms · Canada | 3 | Completed | Oct 2013 | 108 |
| NCT00988897Colorectal Neoplasms · Canada | 2 | Withdrawn | May 2012 | 0 |
| NCT00816543Stomach Neoplasms · Korea, Republic of | 2 | Completed | May 2012 | 41 |
| NCT00782041Uterine Neoplasms · Thailand | 2 | Terminated | Aug 2003 | 11 |
| NCT00612495Endometrial Neoplasms · France | 2 | Completed | 31 | |
| NCT00611962Neoplasms, Germ Cell and Embryonal · France | 2 | Completed | 27 | |
| NCT00611754Head and Neck Neoplasms · France | 2 | Completed | 15 | |
| NCT00611507Stomach Neoplasms · Colombia | 2 | Completed | 21 | |
| NCT00559455Carcinoma, Hepatocellular · Korea, Republic of | 2 | Completed | Jan 2010 | 38 |
| NCT00499850Adenocarcinoma · Australia | 1 | Completed | Jun 2006 | 18 |
| NCT00471965Carcinoma, Hepatocellular · China, Korea, Republic of, Taiwan and more | 3 | Completed | Mar 2010 | 371 |
| NCT00436800Nasopharyngeal Neoplasms · Hong Kong | 2 | Completed | Oct 2008 | 41 |
| NCT00421824Rectal Neoplasms · Spain | 2 | Completed | Nov 2010 | 108 |
| NCT00411229Stomach Neoplasms · China, Korea, Republic of, Taiwan | 3 | Completed | Nov 2012 | 1,035 |
| NCT00403624Rectal Neoplasms | 2 | Completed | Nov 2005 | 38 |
| NCT00399750Colorectal Neoplasms · United States | 2 | Completed | 373 | |
| NCT00382720Stomach Neoplasms · United States, Belgium, France and more | 2 | Completed | Apr 2010 | 275 |
| NCT00356122Carcinoma, Non-Small-Cell Lung · United States | 2 | Completed | Aug 2010 | 53 |
| NCT00296816Ovarian Neoplasms · United States | 2 | Completed | Aug 2011 | 132 |
| NCT00280618Carcinoma, Hepatocellular | 2 | Completed | Nov 2006 | |
| NCT00275210Colonic Neoplasms · Australia, Austria, Belgium and more | 3 | Completed | Apr 2003 | 2,246 |
| NCT00271271Carcinoma, Non-Small-Cell Lung · France | 2 | Completed | 40 | |
| NCT00263354Stomach Neoplasms | 2 | Completed | Jul 2006 | 20 |
| NCT00263055Colonic Neoplasms · China, Hong Kong, Korea, Republic of and more | 4 | Completed | Jun 2005 | |
| NCT00263029Rectal Neoplasms | 2 | Completed | Mar 2007 | 18 |
| NCT00261092Pancreatic Neoplasms · Korea, Republic of | 2 | Completed | 48 | |
| NCT00259363Rectal Neoplasms · Spain | 2 | Terminated | Jun 2006 | 46 |
| NCT00174616Rectal Neoplasms · Belgium, France, Germany and more | 2 | Completed | Nov 2007 | 87 |
| NCT00174564Biliary Tract Neoplasms | 2 | Completed | Sep 2006 | 67 |
| NCT00129870Colorectal Neoplasms · United States | 4 | Terminated | 180 | |
| NCT00094965Gastrointestinal Neoplasms · United States | 2 | Completed | Aug 2007 | 43 |
| NCT00012389Colorectal Neoplasms · United States, Brazil, Canada and more | 3 | Completed | ||
| NCT00008281Colorectal Neoplasms · United States, Canada | 3 | UNKNOWN |
How it is read
Names in the registry
- “Oxaliplatin”, 51 entries
- “oxaliplatin”, 20 entries
- “Oxaliplatin (SR96669)”, 3 entries
- “oxaliplatin (OXA), levofolinate calcium (l-LV), 5-FU, panitumumab”, 3 entries
- “OXALIPLATIN”, 3 entries
Conditions, from the studies’ own filings
- Colorectal Neoplasms, 35 studies
- Stomach Neoplasms, 16 studies
- Pancreatic Neoplasms, 7 studies
- Rectal Neoplasms, 6 studies
- Carcinoma, Hepatocellular, 4 studies
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.